Petra Scheerbaum

Mrs. Petra Scheerbaum

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
PSPetra Scheerbaum
Petra Scheerbaum
SBStephanie Book
Stephanie Book
MJMichael Jank
Michael Jank
Etienne HanslianEtienne Hanslian
Etienne Hanslian
MDMelanie DellO’ro
Melanie DellO’ro
EGElmar Graessel
Elmar Graessel
Introduction: People with mild cognitive impairment (MCI) are at increased risk of decreasing cognitive functioning. Computerised cognitive training (CCT) and nutrition have been shown to improve the cognitive capacities of people with MCI. For each variable, we developed two kinds of interventions specialised for people with MCI (CCT: ‘individualised’ CCT; nutrition: a whole-food, plant-based diet). Additionally, there are two kinds of active control measures (CCT: ‘basic’ CCT; nutrition: a healthy diet following the current guidelines of the German Nutrition Society). The aim of this study is to investigate the effects of the two interventions on cognition in people with MCI in a 2×2 randomised controlled trial with German participants. Methods and analysis: Participants will be community-dwelling individuals with a psychometric diagnosis of MCI based on the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination. With N=200, effects with an effect size of f ≥0.24 (comparable to Cohen’s d ≥0.48) can be detected. Screening, baseline, t6 and t12 testing will be conducted via a videoconferencing assessment, telephone, and online survey. Participants will be randomly allocated to one of four groups and will receive a combination of CCT and online nutritional counselling. The CCT can be carried out independently at home on a computer, laptop, or tablet. Nutrition counselling includes 12 online group sessions every fortnight for 1.5 hours. The treatment phase is 6 months with follow-ups after six and 12 months after baseline. Ethics and dissemination: All procedures were approved by the Friedrich-Alexander-Universität Erlangen-Nürnberg Ethics Committee (Ref. 21-318-1-B). Written informed consent will be obtained from all participants. Results will be published in peer-reviewed scientific journals, conference presentations. Trial registration number: ISRCTN10560738 .

23 February 2024 in Das Gesundheitswesen
Verified
Journal Article
Open access
PDF file
PSPetra Scheerbaum
Petra Scheerbaum
EGElmar Gräßel
Elmar Gräßel
CWCatharina Wasic
Catharina Wasic
APAnna Pendergrass
Anna Pendergrass
Zusammenfassung: Ziel Pflegebedürftige Menschen in Deutschland werden im Rahmen der häuslichen Pflege hauptsächlich von ihren Angehörigen versorgt, die dabei unterschiedliche Entlastungs- und Unterstützungsangebote in Anspruch nehmen. Ziel dieser Studie ist es, die Häufigkeit der tatsächlichen Nutzung sowie die gewünschte Nutzung von ambulanten Entlastungs- und Unterstützungsangeboten zu ermitteln. Als Ursache für die Pflegebedürftigkeit werden dabei Demenzerkrankungen und Nicht-Demenzerkrankungen unterschieden.Methodik Die Daten stammen aus einer repräsentativen Stichprobe pflegender Angehöriger von gesetzlich versicherten Pflegebedürftigen, die vom MD Bayern zur Pflegegradeinstufung begutachtet wurden (N=958). Die Nutzung folgender ambulanter Entlastungs- und Unterstützungsangebote wurde untersucht: ambulanter Pflegedienst, Haushaltshilfe, Tagespflege, Essen auf Rädern, Fahrdienst, Betreuungsdienst, 24-Stunden-Betreuung und Betreuungsgruppe. Charakteristika der pflegebedürftigen Personen, der pflegenden Angehörigen und der Pflegesituation wurden erfasst. Unterschiedsanalysen wurden mittels Chi2-Tests sowie t-Tests durchgeführt. Ergebnisse Die Inanspruchnahme der ambulanten Unterstützungsangebote fiel trotz hoher Pflegebelastung der pflegenden Angehörigen eher gering aus: Sie reichte von 1,7% bei der Betreuungsgruppe bis 38,4% beim ambulanten Pflegedienst. Über 40% der Befragten nutzten keines der acht Angebote. Von diesen Nicht-Nutzern hatten jedoch 72% den Wunsch, in Zukunft mindestens eines dieser Angebote nutzen zu wollen. Die Haushaltshilfe und der ambulante Pflegedienst waren von den Nicht-Nutzern die am häufigsten gewünschten Angebote. Bei Demenzerkrankungen war die tatsächliche und gewünschte Nutzung, insbesondere bei Tagespflege, Betreuungsgruppe und Betreuungsdienst, häufiger als bei anderen Ursachen der Pflegebedürftigkeit. Schlussfolgerung Der Wunsch nach Nutzung ist deutlich höher als die Wirklichkeit der Inanspruchnahme, die bei ambulanten Entlastungsangeboten von niedrigen Nutzungsraten geprägt ist. Es gilt, die Ursachen für diese Diskrepanz zu erforschen. Daraus sollten wirksame Strategien entwickelt werden, die pflegenden Angehörigen so zu beraten, dass passende Entlastungsangebote die pflegenden Familien auch erreichen und damit die häusliche Pflegesituation stärken.

10 August 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
PSPetra Scheerbaum
Petra Scheerbaum
EGElmar Graessel
Elmar Graessel
SBSophia Boesl
Sophia Boesl
Etienne HanslianEtienne Hanslian
Etienne Hanslian
CKChristian S. Kessler
Christian S. Kessler
JSJulia-Sophia Scheuermann
Julia-Sophia Scheuermann
Limitations in daily living have not yet been described adequately for mild cognitive impairment (MCI). In this study, we investigated first, time spent on protective activities (social, mental, and physical) and second, limitations in practical skills of daily living, both for people with MCI. We used baseline data from 270 individuals who participated in the randomized controlled trial BrainFit-Nutrition. The Montreal Cognitive Assessment (MoCA) was used to identify people with MCI. Participants were asked how much time they spent engaged in social, mental, and physical activities each week. Furthermore, the Bayer-ADL scale was used to quantify deficits in activities of daily living (ADLs). Regarding protection, the number of hours spent engaged in the three activity areas was significantly correlated with the cognitive performance in people with MCI. Social activities were positively associated with current cognitive performance. Concerning the limitations in practical skills of daily living, older and more cognitively impaired individuals were affected. Memory and orientation appear to be among the first practical skills of daily living that become impaired in people with MCI. Treatment recommendations for people with MCI include an increase in social, mental, and physical activities as well as the promotion of a healthy lifestyle.

8 November 2024 in Journal of Alzheimer’s Disease
Verified
Journal Article
Open access
JSJulia-Sophia Scheuermann
Julia-Sophia Scheuermann
EGElmar Graessel
Elmar Graessel
AKAndré Kratzer
André Kratzer
PSPetra Scheerbaum
Petra Scheerbaum
Background: Mild cognitive impairment (MCI) and mild behavioral impairment (MBI) are both considered potential prodromal stages of dementia, especially Alzheimer's disease. Previous literature has lacked specific information about MBI in individuals with MCI and associations of several aspects of both, MBI and MCI. Objective: Our aim was to investigate whether associations exist between aspects of MBI and aspects of cognitive performance in certain dimensions of the Montreal Cognitive Assessment (MoCA). Methods: We used baseline data from the double-blind randomized controlled intervention MCI-CCT-study. Current cognitive performance of individuals with MCI was measured with the MoCA. MBI was assessed with the MBI Shortscale (MBI short), which was administered through a self-report interview. Associations were assessed with Pearson correlations. Sensitivity analyses were conducted for gender and cognition. Group differences were examined with independent samples t-tests or Welch test. Significant correlations were considered in binary logistic regressions under control of covariates. Results: There was no significant correlation between the current MoCA and MBI short scores in the total sample or in the gender-related analysis. Using dichotomized cognitive performance, significant correlations between MCI and MBI were revealed for individuals with lower MoCA scores. On the task level, several significant associations were identified between MoCA dimensions and MBI dimensions in the total sample and in the sensitivity analyses, also under control of covariates. Conclusions: Our findings support the hypothesis that with increasing cognitive decline, the association between MCI and MBI becomes stronger. Furthermore, a certain cut-off on the MoCA must be reached to identify a correlation.

24 May 2025 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
SBSophia Bösl
Sophia Bösl
PSPetra Scheerbaum
Petra Scheerbaum
EGElmar Graessel
Elmar Graessel
CKChristian S. Kessler
Christian S. Kessler
JSJulia-Sophia Scheuermann
Julia-Sophia Scheuermann
Objective: The aim of this study was to compare the Montreal Cognitive Assessment (MoCA) performances of people who report no, subclinical, and clinical symptoms of depression. Methods: Data was collected for the randomized controlled trial BrainFit-Nutrition. A secondary data analysis of 1,111 participants (age ≥ 60 years; M = 68.4 years; 55.1% female) was performed. Depressive symptoms were assessed with the Patient Health Questionnaire-9 (PHQ-9), cognitive performance was assessed via the MoCA. Performance differences were tested with Kruskal-Wallis tests. Two sensitivity analyses were conducted, one with data from people with MCI and one with the original item structure of the MoCA. Results: No differences were found in the MoCA total score or in visuospatial, executive functioning, attention, memory, or orientation subscores between individuals with no, subclinical, or clinical symptoms of depression. A sensitivity analysis also showed no differences. Conclusion: Cognitive screening with the MoCA seems to be robust against depression and could therefore be used to screen for MCI regardless of depression level. Trial registration: The study was prospectively registered at the International Standard Randomized Controlled Trial Number Registry on 23/11/2021 (ISRCTN 10560738).

30 April 2025 in BMJ Open
Verified
Journal Article
Open access
PDF file
JSJulia-Sophia Scheuermann
Julia-Sophia Scheuermann
PSPetra Scheerbaum
Petra Scheerbaum
YLYu Liu
Yu Liu
YDYaping Ding
Yaping Ding
JLJianwen Lu
Jianwen Lu
AKAndré Kratzer
André Kratzer
Introduction The prevalence of dementia is increasing, both worldwide and in China. This disease is associated with numerous restrictions for those affected but also for caregivers and society. Due to the limited effectiveness of pharmacological interventions, more research on non-pharmacological interventions is needed. For the non-pharmacological multimodal MAKS (M: motor training, A: activities of daily living training, K: cognitive training, S: social-communicative setting) intervention, positive effects on cognition, activities of daily living, and the occurrence of behavioural and psychological symptoms of dementia were identified in two randomised controlled trials in different settings in Germany. Thus, the German MAKS intervention was culturally adapted for China and will now be tested for its efficacy in Chinese nursing homes in a randomised controlled trial. Methods and analysis Participants will be residents of Chinese nursing homes in Shenyang, Nanjing and Dalian, fulfilling the ICD-10 criteria for Alzheimer’s dementia, the psychometric criteria for mild to moderate dementia (MMSE 10–23) and none of the exclusion criteria. With n=200, effects with an effect size of Cohen’s d=0.45 and a power of 1-β = 0.80 can be detected. Screening and data collection at baseline, t6 and t12 will be conducted via face-to-face contact by proxy raters in the nursing homes (i.e., trained nursing staff not involved in the intervention) and master students as external testers for the performance tests on cognition and activities of daily living. Participants will be randomly allocated to the intervention or control group. SinoMAKS (i.e., the Chinese version of the MAKS intervention) will be conducted at least three times a week for six months by trained MAKS therapists. The control group will receive care as usual for 12 months after baseline. Thus, the treatment phase is six months with follow-ups after six and 12 months after baseline. In the open phase, from t6 to t12, the nursing homes are free to offer SinoMAKS to the intervention group residents. In line with international guidelines, the primary population for analysis is the intention-to-treat sample. Global cognition (measured with the Addenbrooke’s Cognitive Examination-III) is the primary outcome. The hypotheses will be analysed using multiple linear regression with the outcome variables as dependent variables. Ethics and dissemination All procedures were approved by the Ethics Committee of the Medical Faculty of the Friedrich-Alexander-Universität Erlangen-Nürnberg (Ref. 24–162-B) and the Ethics Committee of the China Medical University (Ref. [2024]181). Written informed consent will be obtained from all participants or—if applicable—their legal representatives. Results will be published in peer-reviewed scientific journals and conference presentations. Trial registration number ISRCTN10262531.